Two Sigma Advisers’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $349K | Buy |
|
|||||
|
2025
Q2 | $448K | Sell |
|
|||||
|
2025
Q1 | $249K | Sell |
|
|||||
|
2024
Q4 | $272K | Sell |
|
|||||
|
2024
Q3 | $248K | Buy |
|
|||||
|
2024
Q2 | $155K | Sell |
|
|||||
|
2024
Q1 | $293K | Sell |
|
|||||
|
2023
Q4 | $207K | Sell |
|
|||||
|
2023
Q3 | $198K | Buy |
|
|||||
|
2023
Q2 | $156K | Sell |
|
|||||
|
2023
Q1 | $122K | Buy |
|
|||||
|
2022
Q4 | $125K | Buy |
|
|||||
|
2022
Q3 | $68K | Sell |
|
|||||
|
2022
Q2 | $85K | Sell |
|
|||||
|
2022
Q1 | $244K | Sell |
|
|||||
|
2021
Q4 | $905K | Buy |
|
|||||
|
2021
Q3 | $1.04M | Buy |
|
|||||
|
2021
Q2 | $1.36M | Sell |
|
|||||
|
2021
Q1 | $3.28M | Buy |
|
|||||
|
2020
Q4 | $993K | Sell |
|
|||||
|
2020
Q3 | $980K | Buy |
|
|||||
|
2020
Q2 | $2.62M | Buy |
|
|||||
|
2020
Q1 | $209K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $483K | Sell |
|
|||||
|
2018
Q1 | $788K | Sell |
|
|||||
|
2017
Q4 | $1.25M | Buy |
|
|||||
|
2017
Q3 | $1.54M | Buy |
|
|||||
|
2017
Q2 | $378K | Buy |
|